Skip to content

Author

Azita Asadi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Linarin Reverses Doxorubicin Resistance by Modulating PTEN and MDR1 Expression in MCF-7 Breast Cancer Cells

Linarin may represent a promising adjunct therapeutic agent for overcoming resistance to conventional chemotherapeutic drugs, mediated through PTEN upregulation, which appears to play a role in suppressing P-gp-associated resistance mechanisms.

Vahid Mahmoudzadeh, Mehran Molavand, Azita Asadi et al. · 0 citations
Review Aug 2026

Regulation of PI3K Signaling by lncRNAs in Breast Cancer: A Mini-Review.

This mini-review synthesizes recent evidence on lncRNAs targeting the PI3K/AKT/mTOR cascade in breast cancer, summarizing molecular mechanisms, functional consequences for proliferation, invasion, and therapy resistance, and available in vitro and in vivo evidence.

Azita Asadi, Mehran Molavand, B. Yousefi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.